Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rockwell Medical (RMTI) EPS (Basic): 2009-2025

Historic EPS (Basic) for Rockwell Medical (RMTI) over the last 17 years, with Sep 2025 value amounting to -$0.05.

  • Rockwell Medical's EPS (Basic) fell 200.00% to -$0.05 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.18, marking a year-over-year decrease of 260.00%. This contributed to the annual value of -$0.03 for FY2024, which is 91.89% up from last year.
  • Rockwell Medical's EPS (Basic) amounted to -$0.05 in Q3 2025, which was down 0.00% from -$0.05 recorded in Q2 2025.
  • In the past 5 years, Rockwell Medical's EPS (Basic) registered a high of $0.05 during Q3 2024, and its lowest value of -$1.04 during Q4 2021.
  • In the last 3 years, Rockwell Medical's EPS (Basic) had a median value of -$0.05 in 2025 and averaged -$0.05.
  • Its EPS (Basic) has fluctuated over the past 5 years, first slumped by 1,055.56% in 2021, then spiked by 171.43% in 2024.
  • Quarterly analysis of 5 years shows Rockwell Medical's EPS (Basic) stood at -$1.04 in 2021, then soared by 95.19% to -$0.05 in 2022, then climbed by 0.00% to -$0.05 in 2023, then increased by 20.00% to -$0.04 in 2024, then tumbled by 200.00% to -$0.05 in 2025.
  • Its EPS (Basic) stands at -$0.05 for Q3 2025, versus -$0.05 for Q2 2025 and -$0.04 for Q1 2025.